Navigation Links
Rock concert aids cancer research
Date:1/18/2011

Rock legends The Who performed alongside Jeff Beck, Blondie singer Debbie Harry and The Verve's Richard Ashcroft. They wowed a packed house and glittering list of celebrities to raise funds for PDT.

The work carried out by Dr. Alison Curnow and her team at the Peninsula Medical School and Royal Cornwall Hospital in Truro, UK, was given an immediate grant from the Killing Cancer charity of 30,000, which came from the proceeds of the concert.

Dr. Curnow commented: "The Peninsula Medical School PDT research team and the very busy dermatology PDT service led by Dr. Sandra Campbell at the Royal Cornwall Hospital are delighted with the generous support provided by Killing Cancer. It was a fantastic show and this funding will enable us to continue our clinical PDT research for another year. PDT is still a relatively little know light-activated anti-cancer drug therapy that can be used topically to destroy certain types of skin cancer without scarring."

David Longman, director of Killing Cancer, added: "Alison's team is doing amazing work in Cornwall. The concert was a great success and it was good to be able to make an immediate grant to recognise quickly the way Alison and her team are developing the use of PDT. The charity and the rock legends who supported us wanted to recognise the incredible research work, dedication and determination of Alison and her team."


'/>"/>

Contact: Andrew Gould
andrew.gould@pcmd.ac.uk
44-139-268-6107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Page: 1

Related medicine news :

1. dbMaestro Achieves “Ready For IBM Rational Software” Validation For Rational Team Concert Integration
2. Hospitals and Health Systems Have a New Solution for Zero Footprint Image Exchange; Orion Health Announces Concerto Enterprise Image Viewer
3. U-M researchers find indirect path to attack breast cancer stem cells
4. Oncology basic research director at John Theurer Cancer Center continues transplantation research
5. Scientists bring cancer cells back under control
6. Scientists identify avoidable breast cancer risk factors
7. Clinicians cite time, patient embarrassment as barriers to performing skin cancer exams
8. Thorough Exams a Must for Those at High Risk of Skin Cancer
9. Breast Cancer Radiation Before 1984 Tied to Heart Disease
10. Study Finds Racial Disparity in Breast Cancer Outcomes
11. Study provides molecular rationale for combining targeted agents to treat breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: